AcelRx Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.11.23	AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
10.08.23	AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
10.05.23	AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
30.03.23	AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update (PR Newswire)
14.03.23	AcelRx Pharma Announces Divestment Of DSUVIA - Quick Facts (RTTNews)
14.11.22	AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update (PR Newswire)
11.08.22	AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update (PR Newswire)
16.05.22	AcelRx Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update (PR Newswire)
10.03.22	AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results (PR Newswire)
15.11.21	Pre-market Movers: CREX, BTB, EYPT, OXBR, MICT… (RTTNews)
15.11.21	AcelRx Pharma Posts Narrower Loss In Q3; To Acquire Lowell Therapeutics (RTTNews)
15.11.21	AcelRx Pharmaceuticals to Acquire Lowell Therapeutics and Reports Third Quarter 2021 Financial Results (PR Newswire)
19.08.21	Pre-market Movers: SONN, ESGC, RSLS, DLO, CHRS, VRPX… (RTTNews)
16.08.21	AcelRx Pharmaceuticals Reports Second Quarter 2021 Financial Results (PR Newswire)
09.08.21	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
04.08.21	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
29.07.21	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
28.07.21	Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX) (PR Newswire)
23.07.21	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX) (PR Newswire)
21.07.21	The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) Investors (PR Newswire)
18.07.21	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
18.07.21	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
14.07.21	AcelRx Reaches Licensing Deal For DZUVEO In Europe And In-licensing Deal For Two Products In US (RTTNews)
14.07.21	AcelRx Enters into Licensing Agreement for DZUVEO® in Europe and In-licensing Agreement for Two Products in the U.S. (PR Newswire)
10.07.21	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
02.07.21	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
01.07.21	Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX) (PR Newswire)
23.06.21	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX) (PR Newswire)
16.06.21	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX (PR Newswire)
08.06.21	Pomerantz Law Firm Announces the Filing of a Class Action Against AcelRx Pharmaceuticals, Inc. and Certain Officers - ACRX (PR Newswire)
17.05.21	EARNINGS SUMMARY: Details of AcelRx Pharmaceuticals Inc. Q1 Earnings Report (RTTNews)
21.01.21	PFE/BNTX Covid Jab Neutralizes UK Strain, Pura Vida Ups Stake In OCX, Woodcock Is Interim FDA Chief (RTTNews)
20.01.21	Pre-market Movers In Healthcare Sector: LCTX, DARE, SRNE, NOVN, HSTO… (RTTNews)
10.08.20	Pre-market Movers In Healthcare Sector: TRVN, ETON, FENC, OPGN… (RTTNews)
20.07.20	Pre-market Movers In Healthcare Sector: TNXP, IBIO, VCNX, AZN, APDN... (RTTNews)
17.07.20	Pre-market Movers In Healthcare Sector: BNGO, ACRX, NBRV, HTBX... (RTTNews)
05.06.20	CYCN Awaits Sickle Cell Disease Data, TTPH Finalizes Its Suitor, ADMS Faces FDA In Feb (RTTNews)
17.03.20	BNTX Soars On COVID-19 Alliance, DBVT Plunges, OPGN Jumps 101%, ACRX Buys TTPH (RTTNews)
29.10.18	Biotech Stocks Facing FDA Decision In November (RTTNews)
24.10.18	CORV Is Back, SENS' Eversense Gets Aetna Coverage, ACRX Nears FDA Decision Day (RTTNews)
15.10.18	FDA Panel Backs ACRX's Pain Drug, ALL Eyes On EARS, TNDM On Watch (RTTNews)
11.10.18	ACRX Nears D-day, TRVN On Watch, All's Well With CRSP, TearLab Disappointed (RTTNews)
07.10.18	Week Ahead In Pharmaceuticals: 6 Stocks To Watch (BPMC, BHC, ACRX...) (RTTNews)
03.10.18	AVRO Down 60% In 2 Days, MESO On Watch, ACRX Faces FDA Panel Next Week (RTTNews)
28.09.18	Biotech Stocks Facing FDA Decision In October (RTTNews)
25.09.18	AMRN Heartens Investors, AKCA On Watch, ACRX Faces FDA Panel In Oct. (RTTNews)
12.09.18	FOMX Soars On Acne Trial Data, GLPG Abuzz, ACRX To Face FDA Panel In Oct. (RTTNews)
12.07.18	AKCA Gets EC Nod, FDA Panel To Review Malaria Drug Today, OVID Awaits Data In Q3 (RTTNews)
28.06.18	ACRX Gets EC Nod, AQXP Tanks As LEADERSHIP 301 Fails, ZSAN Catches Eye (RTTNews)
24.05.18	AcelRx announces FDA acceptance of NDA for DSUVIA (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu AcelRx Pharmaceuticals Inc.

Aktien Top/Flop

Meistgelesene Nachrichten